Zoetis - Beransa The Complete Story Webinar Series - Global Pharmacovigilance of Bedinvetmab

The use of Beransa to treat canine osteoarthritis pain is a hot topic right now. This webinar series is designed to bring you the most up-to-date and accurate scientific data to provide you with the complete story regarding Beransa, separating fact from fiction and providing you with the information you need to make informed, evidence-based therapy decisions for your osteoarthritic patients,in partnership with pet owners. In the second session of the Beransa: The Complete Story series, Dr. Monteiro will present the findings of a 2025 publication, discussing the comprehensive global safety data on bedinvetmab, based on over 18 million doses administered worldwide. This webinar offers a timely, science-led perspective on what the data shows with regard to the rarity of reported adverse events in real world use — and how veterinarians can navigate client conversations with confidence. A live Q&A with Dr. Monteiro will follow at the end of the presentation. Presented by Dr. Beatriz Monteiro, DVM, PhD in Chronic Pain, ISFMAdvCertFB, PgDip, DACAW; Board Certified in Animal Welfare. Director of Veterinary Operations Pain, Global Medical Affairs, Zoetis